Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation
暂无分享,去创建一个
S. Davies | M. Jordan | Ashish R. Kumar | S. Chandrakasan | P. Khandelwal | R. Marsh | M. Grimley | S. Chandra | J. Bleesing | Christa Krupski | B. D. Dávila Saldaña